Janus Henderson Group PLC Axonics, Inc. Transaction History

Janus Henderson Group PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$67.3 - $69.67 $586,048 - $606,686	-8,708 Reduced 4.63%	179,320 $12.5 Million
Q2 2024 Aug 14, 2024	BUY	$66.47 - $69.65 $645,157 - $676,022	9,706 Added 5.44%	188,028 $12.6 Million
Q1 2024 May 15, 2024	BUY	$56.67 - $69.36 $8.74 Million - $10.7 Million	154,149 Added 637.69%	178,322 $12.3 Million
Q4 2023 Feb 14, 2024	SELL	$49.38 - $63.75 $1,876 - $2,422	-38 Reduced 0.16%	24,173 $1.5 Million
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $145 - $187	3 Added 0.01%	24,211 $1.36 Million
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $301,233 - $377,938	6,277 Added 35.01%	24,208 $1.22 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $495,649 - $634,544	9,423 Added 110.75%	17,931 $978,000
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $506,736 - $651,712	8,508 New	8,508 $532,000
Q3 2022 Nov 14, 2022	SELL	$57.96 - $78.12 $76,797 - $103,509	-1,325 Reduced 16.92%	6,508 $458,000
Q2 2022 Aug 15, 2022	BUY	$39.5 - $64.42 $67,663 - $110,351	1,713 Added 27.99%	7,833 $445,000
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $87 - $125	2 Added 0.03%	6,120 $383,000
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $305,961 - $448,755	6,118 New	6,118 $342,000

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.